Peripheral Restricted Diffusion: A Common Appearance of Hepatic Abscesses

Mark M Hammer1, Vincent M Mellnick, Constantine A Raptis

  • 1From the Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO.

Abstract

Insights

Liver abscesses show varied diffusion restriction patterns, with central restriction seen in only 26% of cases. Peripheral restriction was more common, highlighting the need for caution when differentiating abscesses from neoplasms.

Area of Science:

  • Radiology
  • Medical Imaging
  • Hepatology

Background:

  • Diffusion-weighted imaging (DWI) is crucial for diagnosing liver abscesses.
  • The classic central diffusion restriction pattern is often considered typical for hepatic abscesses.

Purpose of the Study:

  • To evaluate the frequency of the classic, central diffusion restriction pattern in hepatic abscesses compared to other patterns.
  • To assess the association between diffusion restriction patterns and clinical factors.

Main Methods:

  • Retrospective review of 42 hepatic abscesses.
  • Three independent reviewers assessed diffusion restriction patterns (central vs. noncentral).
  • Clinical data including symptom duration, organism, and leukocyte values were analyzed.

Main Results:

  • Diffusion restriction patterns were variable; only 26% of lesions showed a central pattern.
  • Peripheral restriction was observed in 42% of cases.
  • Central diffusion restriction was associated with smaller abscess size; symptom duration was not associated with pattern.

Conclusions:

  • Hepatic abscesses exhibit a more variable diffusion restriction pattern than previously recognized.
  • Both central and peripheral diffusion restriction patterns are frequently observed.
  • The variability in appearance necessitates caution when differentiating liver abscesses from neoplasms due to potential overlap in imaging features.

Related Concept Videos

Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
369
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
695
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Non-Oral Extravascular Drug Absorption Routes01:15

Non-Oral Extravascular Drug Absorption Routes

Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
657
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
372